MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Compliance Implementation Services
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CIS Expands its Team to Serve Pharma Industry’s Increasing Need for Clinical Compliance Services - CIS has announced that Diane Dellaratta, Billy Grimme, and Karen Chaney will assume clinical consultant positions with varying degrees of responsibility within CIS’ clinical team headed by Annette Horner, senior director of global clinical compliance
CIS Expands its Team to Serve Pharma Industry’s Increasing Need for Clinical Compliance Services

 

NewswireToday - /newswire/ - Media, PA, United States, 2011/03/31 - CIS has announced that Diane Dellaratta, Billy Grimme, and Karen Chaney will assume clinical consultant positions with varying degrees of responsibility within CIS’ clinical team headed by Annette Horner, senior director of global clinical compliance.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, today announced that it is solidifying its clinical compliance expertise and service offerings amidst a more highly regulated pharma landscape with respective hires of three new regulatory specialists.

With the increase in global clinical trials, including an expanded FDA foreign presence, and the demand for more outsourced services, both sponsors and contract organizations are facing more frequent and rigorous GCP inspections.

“Companies need to take proactive measures to mitigate the overall compliance risk to their organization,” said Annette Horner, CIS senior director of global clinical compliance. “They need a partner that understands regulations from a global perspective and can provide necessary guidance. The addition of new team members, each of whom has strong clinical and regulatory experience, will allow CIS to better serve clients who are feeling the pressures of this increased compliance scrutiny.”

Joining CIS are Diane Dellaratta, senior clinical compliance specialist and project manager; Billy Grimme, senior clinical compliance specialist and project manager and Karen Chaney, clinical compliance specialist.

Diane Dellaratta joins CIS from Pfizer (formerly Wyeth) where she served as a global laboratory and vendor quality monitor specialist. She has strong industry experience in clinical vendor management, clinical vendor auditing, research and development, and clinical laboratory management, having also worked for GlaxoSmithKline, Quest Diagnostics, and Merck & Co. Diane is a member of the American Society for Microbiology, as well as the Biotech and Pharma Professionals Network. She holds a Bachelors of Science degree in microbiology from Pennsylvania State University in University Park, Pennsylvania.

Billy Grimme joins CIS from PPD Inc., where he served as a lead clinical research associate across various clinical trials. He has solid clinical and regulatory expertise through extensive global clinical site monitoring, vendor management, and investigator site qualifications/audits. Billy is skilled in standard operating procedure review, gap analysis, and global process harmonization/improvement consulting engagements. He holds a Bachelor of Science degree in biological sciences from North Carolina State University in Raleigh, North Carolina.

Karen Chaney joins CIS from PPD Inc., where she served as clinical administration manager across various clinical trials. She has clinical and regulatory expertise in process/training development and implementation as well as vendor management. Karen is skilled in standard operating procedure review, gap analysis, and process harmonization/improvement. She holds a Bachelor of Arts degree in psychology from North Carolina State University in Raleigh, North Carolina.

About CIS
Compliance Implementation Services (CIS) is a consulting firm specializing in compliance strategies for the pharmaceutical industry, from Global Clinical Research and Development, through Manufacturing, U.S. Commercial Compliance, and Government Programs. Founded in 2004, CIS (cis-partners.com) provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to establish a “Culture of Compliance” that is both meaningful and sustainable.

CIS experts identify, assess and prioritize an organization’s exposure to compliance risks, subsequently developing and implementing risk evaluation and mitigation techniques to ensure adherence to legal and regulatory requirements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Compliance Implementation Services

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CIS Expands its Team to Serve Pharma Industry’s Increasing Need for Clinical Compliance Services

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Marni Schribman - CIS-Partners.com 
484-445-7200 marnischribman[.]cis-partners.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Compliance Implementation Services securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Compliance Implementation Services / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  JobsWare.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)